Non-correlation between Debrisoquine and Metoprolol Polymorphisms in the Venda
- 1 September 1989
- journal article
- research article
- Published by SAGE Publications in Human Toxicology
- Vol. 8 (5) , 365-368
- https://doi.org/10.1177/096032718900800506
Abstract
1 The metabolic 4-hydroxylation of debrisoquine has been studied in a group of 98 black African villagers in Vendaland. 2 The metabolic α-hydroxylation of metoprolol has been studied in 94 of the same black African villagers. 3 A 4% prevalence of poor oxidative metabolism of debrisoquine and a 7.4% incidence of poor oxidation of metoprolol were found. The 4% result for debrisoquine differs considerably from the 19% found in San Bushmen, 30% in Hong Kong Chinese, 9% in Britains and 0% in Nigerians and Japanese, whilst the 7.4% result for metoprolol compares with 8.4% in Britains but differs from 0% in Nigerians and 4.1% in San Bushmen. 4 None of the poor oxidative metabolizers of debrisoquine were also poor oxidative metabolizers of metoprolol. This is contrary to results in British and Nigerian subjects where defective oxidation of metoprolol co-segrates with that of debrisoquine. 5 No similarities were found between the Venda metabolic ratio (MR) distributions and either extensive or poor MR distributions in Britains or Nigerians.Keywords
This publication has 18 references indexed in Scilit:
- Determination of metoprolol and its α-hydroxy metabolite in urine by direct-injection reversed-phase high-performance liquid chromatography with fluorimetric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Metoprolol α-Hydroxylation Polymorphism in the San Bushmen of Southern AfricaHuman Toxicology, 1989
- Assay of debrisoquine and 4-hydroxydebrisoquine in urine by reversed-phase high-performance liquid chromatography using on-line sample clean-up on a standard isocratic chromatographJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Polymorphism of the 4-Hydroxylation of Debrisoquine in the San Bushmen of Southern AfricaHuman Toxicology, 1988
- The Polymorphic Oxidation of ??-Adrenoceptor AntagonistsClinical Pharmacokinetics, 1986
- Metoprolol metabolism and debrisoquine oxidation polymorphism‐ population and family studies.British Journal of Clinical Pharmacology, 1985
- Genetically Determined Variability in Acetylation and Oxidation Therapeutic ImplicationsDrugs, 1985
- Oxidation Phenotype — A Major Determinant of Metoprolol Metabolism and ResponseNew England Journal of Medicine, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980